Showing 141-150 of 174 results for "".
Treatment Guidelines for the PicoWay® Laser System in Skin of Color
https://practicaldermatology.com/topics/general-topics/treatment-guidelines-for-the-picoway-laser-system-in-skin-of-color/22087/Picosecond laser therapy for benign pigmented lesionsHome-Use Laser and Light Devices: Just What the Doctor Ordered
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/home-use-laser-and-light-devices-just-what-the-doctor-ordered/23335/Laser and light-based devices are more at home than ever as lightweight LEDs, wearable technology, and “smart” apps support adherence and enhance efficacy.Tetracyclines: History and Current Formulation Review From a Dermatology Perspective
https://practicaldermatology.com/topics/general-topics/tetracyclines-history-and-current-formulation-review-from-a-dermatology-perspective/21233/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-18/23367/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20790/Smoothing Out Our Understanding of Moisturizers
https://practicaldermatology.com/topics/skin-cancer-photoprotection/smoothing-out-our-understanding-of-moisturizers/20688/New science and new approaches for dry skin.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20570/Case Report: Treatment of Refractory Pemphigus Foliaceus with Rituximab; Financial Matters; AAD; ASDS Resources
https://practicaldermatology.com/youngmd-connect/resident-resource-center/case-report-treatment-of-refractory-pemphigus-foliaceus-with-rituximab-financial-matters-aad-asds-resources/21033/Taking the Time: The Importance of Effective Communication with Patients
https://practicaldermatology.com/topics/general-topics/taking-the-time-the-importance-of-effective-communication-with-patients/21613/The hallmark of good communication with patients is managing expectations.What Do New PhRMA Guidelines Mean for Dermatology?
https://practicaldermatology.com/topics/general-topics/PD0309_04-php/22858/Revisions to the "Code on Interactions" are taking effect, but what do they really mean for the typical clinician?